Target Name: ROCK2
NCBI ID: G9475
Review Report on ROCK2 Target / Biomarker Content of Review Report on ROCK2 Target / Biomarker
ROCK2
Other Name(s): Rho kinase 2 (ROCK2) | p164 ROCK-2 | Rho-associated protein kinase 2 isoform X1 | Rho-associated, coiled-coil-containing protein kinase II | Rho kinase 2 | Rho associated coiled-coil containing protein kinase 2 | Rho associated coiled-coil containing protein kinase 2, transcript variant 1 | Rho-associated protein kinase 2 | ROCK-II | ROCK2 variant 1 | ROCK2_HUMAN | Rho-associated protein kinase 2 (isoform 1) | KIAA0619 | Rho-associated, coiled-coil-containing protein kinase 2 | rho-associated, coiled-coil-containing protein kinase II

ROCK2: A Key Regulator of Cell Signaling Pathways

ROCK2, also known as RhoA-associated protein 2, is a protein that plays a critical role in cell signaling pathways. It is a key regulator of the Rho GTPase pathway, which is a signaling pathway that regulates various cellular processes including cell growth, differentiation , and cytoskeletal organization. ROCK2 is a 21-kDa protein that is expressed in various tissues and cells in the body. Its function is highly conserved across different species, and it has been implicated in various cellular processes including cell migration, invasion, and stress responses.

One of the unique features of ROCK2 is its ability to regulate the Rho GTPase pathway. The Rho GTPase pathway is a complex protein-protein interaction network that is involved in the regulation of cell signaling pathways. It is composed of several proteins that include RhoA, which is the protein that activates the pathway, and several other proteins that participate in the regulation of RhoA activity. ROCK2 is one of the proteins that regulates RhoA activity.

ROCK2 functions as a negative regulator of RhoA. It binds to RhoA and inhibits its activity by a process called negative feedback. This means that when ROCK2 binds to RhoA, it reduces the activity of RhoA, which in turn inhibits the signaling pathway. This feedback loop helps to maintain the stability of the Rho GTPase pathway and ensures that it is not overactive.

The Rho GTPase pathway is involved in many cellular processes, including cell growth, differentiation, and cytoskeletal organization. It is also involved in various signaling pathways, including the F-actinin signaling pathway, the mitochondrial signaling pathway, and the Xuan Ye signaling pathway. ROCK2 is highly conserved across different species, and it has been implicated in various cellular processes, including cell migration, invasion, and stress responses.

ROCK2 has also been shown to play a role in the regulation of cellular stress responses. It has been shown to regulate the expression of genes involved in stress responses, including genes involved in the expression of activating transcription factor-1 (ATF-1), which is a transcription factor that regulates stress responses. ROCK2 has also been shown to regulate the activity of the protein heat shock protein (Hsp)70, which is involved in the regulation of cellular stress responses.

In addition to its role in regulating the Rho GTPase pathway, ROCK2 has also been shown to play a role in the regulation of cellular adhesion. It has been shown to interact with the protein integrin (integrin), which is involved in the regulation of cellular adhesion. This interaction between ROCK2 and integrin suggests that ROCK2 may be involved in the regulation of cellular adhesion, which is a critical process in the regulation of cellular behavior and homeostasis.

ROCK2 has also been shown to play a role in the regulation of cell cycle progression. It has been shown to regulate the activity of the protein kinase p21 (CK-ATPase), which is involved in the regulation of cell cycle progression. This regulation of p21 activity by ROCK2 suggests that it may be involved in the regulation of cell cycle progression and the maintenance of cellular homeostasis.

In conclusion, ROCK2 is a protein that plays a critical role in cell signaling pathways. Its function as a negative regulator of the Rho GTPase pathway and its involvement in the regulation of cellular stress responses, adhesion, and cell cycle progression suggest that it may be a drug target or biomarker for various diseases. Further research is needed to fully understand the role of ROCK2 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Rho Associated Coiled-coil Containing Protein Kinase 2

Functions: Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation

The "ROCK2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ROCK2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ROCR | Rod cGMP phosphodiesterase 6 | ROGDI | ROM1 | ROMO1 | ROPN1 | ROPN1B | ROPN1L | ROR1 | ROR1-AS1 | ROR2 | RORA | RORA-AS1 | RORB | RORC | ROS1 | Roundabout homolog receptor | RP1 | RP1L1 | RP2 | RP9 | RP9P | RPA1 | RPA2 | RPA3 | RPA3P1 | RPA4 | RPAIN | RPAP1 | RPAP2 | RPAP3 | RPAP3-DT | RPE | RPE65 | RPEL1 | RPF1 | RPF2 | RPGR | RPGRIP1 | RPGRIP1L | RPH3A | RPH3AL | RPH3AL-AS1 | RPIA | RPL10 | RPL10A | RPL10AP10 | RPL10AP12 | RPL10AP3 | RPL10AP6 | RPL10AP7 | RPL10AP9 | RPL10L | RPL10P13 | RPL10P16 | RPL10P2 | RPL10P4 | RPL10P6 | RPL10P9 | RPL11 | RPL11P4 | RPL12 | RPL12P32 | RPL12P38 | RPL12P6 | RPL12P7 | RPL13 | RPL13A | RPL13AP16 | RPL13AP17 | RPL13AP20 | RPL13AP22 | RPL13AP23 | RPL13AP25 | RPL13AP3 | RPL13AP5 | RPL13AP6 | RPL13AP7 | RPL13P12 | RPL13P5 | RPL13P6 | RPL14 | RPL14P1 | RPL14P3 | RPL15 | RPL15P11 | RPL15P20 | RPL15P21 | RPL15P22 | RPL15P3 | RPL15P4 | RPL17 | RPL17P25 | RPL17P33 | RPL17P34 | RPL17P39 | RPL17P4 | RPL17P44 | RPL17P49 | RPL17P7